Wan Yantong, Shen Junyi, Hong Yinghao, Liu Jinghua, Shi Tieliu, Cai Junwei
Guangdong Provincial Key Laboratory of Proteomics, Department of Pathophysiology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.
Front Oncol. 2023 Jun 23;13:1181164. doi: 10.3389/fonc.2023.1181164. eCollection 2023.
Melanoma is a skin tumor with a high mortality rate, and early diagnosis and effective treatment are the key to reduce its mortality rate. Therefore, more and more attention has been paid for biomarker identification for early diagnosis, prognosis prediction and prognosis evaluation of melanoma. However, there is still a lack of a report that comprehensively and objectively evaluates the research status of melanoma biomarkers. Therefore, this study aims to intuitively analyze the research status and trend of melanoma biomarkers through the methods of bibliometrics and knowledge graph.
This study uses bibliometrics to analyze research in biomarkers in melanoma, summarize the field's history and current status of research, and predict future research directions.
Articles and Reviews related to melanoma biomarkers were retrieved by using Web of Science core collection subject search. Bibliometric analysis was performed in Excel 365, CiteSpace, VOSviewer and Bibliometrix (R-Tool of R-Studio).
A total of 5584 documents from 2004 to 2022 were included in the bibliometric analysis. The results show that the number of publications and the frequency of citations in this field are increasing year by year, and the frequency of citations has increased rapidly after 2018. The United States is the most productive and influential country in this field, with the largest number of publications and institutions with high citation frequency. Caroline Robert, F. Stephen Hodi, Suzanne L. Topalian and others are authoritative authors in this field, and The New England Journal of Medicine, Journal of Clinical Oncology and Clinical Cancer Research are the most authoritative journals in this field. Biomarkers related to the diagnosis, treatment and prognosis of melanoma are hot topics and cutting-edge hotspots in this field.
For the first time, this study used the bibliometric method to visualize the research in the field of melanoma biomarkers, revealing the trends and frontiers of melanoma biomarkers research, which provides a useful reference for scholars to find key research issues and partners.
黑色素瘤是一种死亡率很高的皮肤肿瘤,早期诊断和有效治疗是降低其死亡率的关键。因此,越来越多的关注集中在黑色素瘤早期诊断、预后预测和预后评估的生物标志物识别上。然而,目前仍缺乏一份全面、客观评价黑色素瘤生物标志物研究现状的报告。因此,本研究旨在通过文献计量学和知识图谱的方法直观分析黑色素瘤生物标志物的研究现状和趋势。
本研究运用文献计量学方法分析黑色素瘤生物标志物的研究情况,总结该领域的研究历史和现状,并预测未来的研究方向。
利用Web of Science核心合集主题检索,检索与黑色素瘤生物标志物相关的文章和综述。在Excel 365、CiteSpace、VOSviewer和Bibliometrix(R-Studio的R工具)中进行文献计量分析。
文献计量分析共纳入2004年至2022年的5584篇文献。结果表明,该领域的发文量和被引频次逐年增加,2018年后被引频次增长迅速。美国是该领域产出最多、影响力最大的国家,发文量最多,且有高被引频次的机构。卡罗琳·罗伯特、F. 斯蒂芬·霍迪、苏珊娜·L. 托帕利安等人是该领域的权威作者,《新英格兰医学杂志》《临床肿瘤学杂志》和《临床癌症研究》是该领域最具权威性的期刊。与黑色素瘤诊断、治疗和预后相关的生物标志物是该领域的热点和前沿热点。
本研究首次运用文献计量学方法对黑色素瘤生物标志物领域的研究进行可视化分析,揭示了黑色素瘤生物标志物研究的趋势和前沿,为学者们寻找关键研究问题和合作伙伴提供了有益参考。